Sitemap

Home page

Medical Communications Agency | Med Comms | Medical Writing Companies

Medical Communications Agency | Rx Communications

Our Team | Rx Communications

Medical Communications | Medical Writing | Rx Communications

Medical Publications | Medical Writing Services Agency | Rx Comms

Communication in Healthcare | Scientific Communication | Rx Comms

Health Economics | Healthcare Economics | HEOR

Evidence Based Medicine | Evidence Based Decision Making | EBM

Process Audits | Publication Policy Development | Rx Comms

Medical Education | Online Med Ed | Medical Writing Company

Creative Health Solutions | Creative Solutions In Healthcare

Health Economics Training & Education Booklets | Rx Comms

Digital Medical Communications | Scientific Communications | Patient Engagement in Healthcare

Patient Information | Patient Engagement Solutions | Rx Comms

RxCommsPlus | Rx Communications

Health Outcomes Communicator | Health Economics Communications

Rx Comms | Global Boutique Medical Communications Agency

What’s keeping people awake at night during such an unprecedented time in their lives? | Rx Communications

Blog | HOC | Rx Communications

Newsletter | HOC | Rx Communications

Uncategorised | HOC | Rx Communications

The role of health economics in meeting increased mental health needs due to COVID-19 | Rx Communications

Emma Donadieu | HOC | Rx Communications

Home schooling? Not what I thought. | Rx Communications

Brexit and coronavirus: a perfect storm for UK drug shortages? | Rx Communications

Drug Shortages: New Light on an Old Problem | Rx Communications

The Future of Medical Conferences is Digital | Rx Communications

Introduction to Health Economics Concepts | Rx Comms

Demonstrating Value in Healthcare | Rx Communications

Why Do Medicines Cost So Much? | Rx Communications

Does online learning have a place in healthcare education? | Rx Communications

Why Online Congresses are Here to Stay | Rx Communications

Exploring a career as a medical writer | Rx Communications

Is Medical Education Failing Our Future Doctors? | Rx Communications

Health Outcomes Communicator | Health Economics Communications

Archives | HOC | Rx Communications

Communications — Rx Communications

Editorial | HOC | Rx Communications

Health Economics | HOC | Rx Communications

heor.tv | HOC | Rx Communications

Hide Author | HOC | Rx Communications

HTA & Market Access | HOC | Rx Communications

Tips & Tools | HOC | Rx Communications

Blog | HOC | Rx Communications

Top 5 Chronic Conditions Affecting the Global Population | Rx Communications

Reimagining the Office During COVID-19 | Rx Communications

Top Ten Health Economics Journals in 2020 | Rx Communications

Newsletter | HOC | Rx Communications

How to Spot Predatory Science | Rx Communications

Rare Diseases - A Growing Focus for Healthcare Product Developers | Rx Communications

Anti-Viral Drugs In Development For COVID-19 | Rx Communications

Communication during Working from home WFH | Rx Communications

The World’s Response to SARS-CoV-2 | Rx Communications

Vaccines in Development For COVID-19 | Rx Communications

Social Media — its ever-increasing importance to clinical research | Rx Communications

Breast cancer blood test can detect early diagnosis. | Rx Communications

New solutions for our staff and clients during the Coronavirus pandemic | Rx Communications

Medical Writing in a Digital Era - 10 Things to Watch in 2020 | Rx Communications

The Queens’ Secret Annamese Fertility Herb Resolves an Unmet Medical Need — on track for FDA Botanical Drug Approval | Rx Communications

The Gold Cape of Mold | Rx Communications

Are we playing God? | Rx Communications

Identifying High-Value Patient Engagement Opportunities | Rx Communications

Empowering patients to take control of their health data: A DIAmond session at DIA San Diego 2019 | Rx Communications

ISPOR Baltimore — Great Information but Medical Writing Training Needed... | Rx Communications

6 Ways to Spot a Predatory Journal | Rx Communications

Understanding the Literature Search Process | Rx Communications

Why Bother with Writing Assistance for HEOR Studies

Understanding Data Retrieval | Effective Literature Reviews

Effective and Efficient Literature Reviews: Actual Data Extraction

What are journal editors looking for from health economists?

Should Quotations Be Used in Medical Marketing Materials?

Health Economics Professionals | Medical Communications Expertise

How to make the best use of graphics | Medical Communications | Medical Writer

Top Tips for Creating Patient Education Material | Medical Communications

Top Ten Patient Education Websites | Patient Education Material

Do Outcome Measures in Pain Trials Hamper Drug Development? | Rx Communications

Rx Communications at the 52nd EASD Annual Meeting | Rx Communications

The New Cancer Drugs Fund Appraisal Process | Rx Communications

A Newcomer’s Viewpoint of the Diabetes UK Conference | Rx Communications

Individualising targets in diabetes: NICE or not NICE? | Rx Communications

mHealth: Current Opportunities and Challenges | Rx Communications

Writing Styles in HEOR Communications | Health Economics Comms

Writing Styles — Let’s hear it for.....the Tuatara | Rx Communications

Writing Styles in Health Economics Communications - Meet the Termite | Rx Communications

How do we really know what people want in terms of healthcare? | Rx Communications

Medical Publications Professionals | Medical Communications

Collaborations Within Medical Publications | Video Interview

Is Regionalisation of Phase IV Trials a Good Thing? | Read On...

Competitive Intelligence and Competitor Strategy | Healthcare Communications

Jargon in Health Economics | Medical Communications | Medical Writer

Evidence matters... of course it does! | Medical Communications Newsletter

Anatomy of a Medical Communications Project Manager | Medical Communications

How to Get Your Research Published | Medical Communications

Biggest challenges facing Chinas healthcare reform? | Medical Communications | Healthcare Communications

ISPOR Abstract Submission Open | Rx Communications

Chinese hospitals 15% mark up encourages use of expensive drugs, how can we change this? | Rx Communications

Can China utilise a Value Based Pricing approach much like the UK? | Rx Communications

The Absence of Clinical Trial Data: Attack on Pharma | Rx Communications

Understanding risk: the patient’s perspective | Rx Communications

How was ISPOR founded? | Rx Communications

How is vision 2020 going to make an impact on patient healthcare? | Rx Communications

Editorial: What’s in a name? Guest authors, ghost authors, and plain ol’ writers | Rx Communications

Health economist, interrupted | Rx Communications

Observational Research in Health Technology Assessment | Rx Communications

The Importance of Good Communications in Rational Decision Making | Rx Communications

Electronic medical publishing: We’re not in Kansas anymore | Rx Communications

Medical publishing, and so much more | Rx Communications

Lies, damn lies, and — or are? — statistics | Rx Communications

Even with numbers, words mean things | Rx Communications

Give me another chance! The NICE technology appeals process is updated | Rx Communications

Why you should learn about the updated NICE appeals process | Rx Communications

Electronic records in the psychiatrist’s office: patients may not mind | Rx Communications

Embracing technology in one of the most personal medical specialties | Rx Communications

Communicating complexity and understanding risk: whose responsibility is it? | Rx Communications

Structural interventions: redesigning society in the name of public health | Rx Communications

The changing landscape of the health technology assessment customer base | Rx Communications

Different Perspectives on Value Based Pricing in the UK | Rx Communications

Thoughts on the proposed UK Value Based Pricing System | Rx Communications

Pricing and Reimbursement in Recession | Rx Communications

Pricing and Reimbursement Challenges in the Netherlands | Rx Communications

ISPOR Efforts in Communication | Rx Communications

Editorial: Putting the squeeze on pharma pricing in the EU | Rx Communications

Pricing policy in Europe: of cars, football, and prescription drugs | Rx Communications

The Painful Effects of Healthcare Reform | Rx Communications

Comparative Effectiveness and Obamacare | Rx Communications

It’s time to set ourselves up for success in managing chronic illness | Rx Communications

Are we getting too much medicine? | Rx Communications

Editorial: Money, sex, fame, and power — understanding motivation | Rx Communications

Editorial: Beyond the headlines: understanding H1N1 vaccine availability | Rx Communications

Will that be hollandaise with your egg, or a side of vaccine? | Rx Communications

ISPOR EU 2009: Bringing the Eiffel Tower into Perspective | Rx Communications

Editorial: Great minds think alike | Rx Communications

A UK perspective: how can the US have reform without rational debate? | Rx Communications

Editorial: US healthcare reform debate devolves into namecalling | Rx Communications

Exorcising the ghosts of medical writing | Rx Communications

Editorial: Re-valuing Email | Rx Communications

Email Etiquette | Rx Communications

‘You say HTA, I say CER’: international perspectives on evidence-based health policy | Rx Communications

Using a worldview of healthcare to understand policy within | Rx Communications

Abstract Submission Deadlines | Rx Communications

Saying it in cyberspace: a guide to successful blogging and twittering | Rx Communications

All the world’s an author | Rx Communications

The art of online networking | Rx Communications

Navigating the uncharted waters of social networking media | Rx Communications

Welcome to our new look at HOC! | Rx Communications

Medical bankruptcy in the USA: the data behind the headlines | Rx Communications

Using Medicare Data to Understand Growth in US Healthcare Costs | Rx Communications

Why HOC online? | Rx Communications

Welcome to our new look HOC! | Rx Communications

Is it time for NICE to revise its threshold? | Rx Communications

Medical writing: vigilance for ethics | Rx Communications

Talking risk: how to communicate health outcomes to non-health economists | Rx Communications

2009 brings a move toward ending pharma freebies | Rx Communications

Medical tourism: way of the future or flight of fancy? | Rx Communications

Universal healthcare in the US? Not yet, but probably soon | Rx Communications

Is it time for a government-run national health system in the US? | Rx Communications

Tough choices about expensive drugs | Rx Communications

“Moving and Improving Concepts and Evidence for Healthcare Decisions” — the latest ISPOR congress | Rx Communications

Access to medicines: Ranking the social responsibility of pharmaceutical companies | Rx Communications

American Medical Writers Association (AMWA) Annual Conference 2008 | Rx Communications

Drug makers gift disclosures: the ethics issue | Rx Communications

Direct-to-Consumer Advertising — in Europe? | Rx Communications

How sick are you? It depends on what the definition of ‘sick is... | Rx Communications

Development Safety Update Reports (DSURs): simplifying periodic safety reporting | Rx Communications

Conquering chaos: six steps to an organised office | Rx Communications

www.PatientsLikeMe.com — The power of patient-provided information | Rx Communications

Canada healthcare — from paper to pixels | Rx Communications

ISMPP: Former Merck CEO outlines three ways pharma companies can regain lost prestige | Rx Communications

Is the value of drug innovation poorly understood? | Rx Communications

Alcohol and global warming — what’s the common theme? | Rx Communications

Meeting the challenge of meetings | Rx Communications

Defining the healthcare debate in the US | Rx Communications

Zen and the art of searching PubMed | Rx Communications

WHCC in Berlin: A glimpse into the future | Rx Communications

Preventing medication errors | Rx Communications

Bringing healthcare to the worksite | Rx Communications

How to hold on to your web visitors | Rx Communications

Association of American Medical Colleges issues task force report on industry funding of medical education | Rx Communications

Why they rejected your manuscript — and what you can do about it | Rx Communications

Increased calls for publishing negative clinical trial data | Rx Communications

Is the NHS on its last legs? | Rx Communications

‘Big box companies and public health | Rx Communications

The mean versus the gene: will national healthcare systems ever adopt personalised medicine? | Rx Communications

Regulating DTC ads — Are we attempting to herd cats? | Rx Communications

The Pharmaceutical industry: Some good news to tell, but not always told well | Rx Communications

Turning layoff lemons into lemonade | Rx Communications

HOC People — Ruth Whittington | Rx Communications

How to improve staff morale | Rx Communications

Pros and cons of direct-to-consumer advertising | Rx Communications

W(h)ither the FDA? | Rx Communications

How to participate in or lead a panel discussion | Rx Communications

How to make sense of health economics | Rx Communications

Training programmes: Where do future health economists come from? | Rx Communications

HOC people: Patti Peeples Gustafson, PhD | Rx Communications

Develop a healthy scepticism about research even in the ‘best’ scientific journals | Rx Communications

The importance of the economic value message | Rx Communications

Dealing with the media — confidently | Rx Communications

Is big pharma becoming big biotech? | Rx Communications

How to be a more effective public speaker | Rx Communications

Wiring healthcare | Rx Communications

A new way for pharmaceutical companies and prescribers to interact? | Rx Communications

You need to know the global issues in health economics | Rx Communications

What is the value of outcomes research? | Rx Communications

AMWA Annual Conference 2007 | Rx Communications

HOC people — Dennis M. Gross, PhD | Rx Communications

Letter to the editor | Rx Communications

Making adherence work for your dollar (or pound, or euro ) | Rx Communications

Outsourcing clinical trials | Rx Communications

Rx attracts strong interest at Dublin ISPOR Conference | Rx Communications

HOC people — Vittorio Maio, PharmD, MPH | Rx Communications

In-store health clinics: a new approach to primary care? | Rx Communications

How to write a good sentence — length and rhythm | Rx Communications

Understanding study design in comparing drug studies | Rx Communications

The “other drug costs” — Part 1: non-adherence | Rx Communications

The power of emotional intelligence | Rx Communications

Sorting out the varying standards for pharmacoeconomic guidelines | Rx Communications

HOC people — David B. Nash, MD, MBA | Rx Communications

Is there a place for healthcare blogs? | Rx Communications

Why not take a ‘sensory break?’ | Rx Communications

HOC people — Diana Brixner | Rx Communications

Simplifying drug labels | Rx Communications

Observational studies: answering real-life questions about healthcare practice | Rx Communications

Big Brother may be reading your emails | Rx Communications

Giving and taking feedback | Rx Communications

Health economists’ broader role in lifestyles, demographics, and risk management | Rx Communications

Observational studies: answering real-life questions about healthcare practice | Rx Communications

Industry commentary — Predictors of productivity | Rx Communications

In praise of eloquence | Rx Communications

Risk/benefit decisions — who should be involved, and are there valid measurement methods? | Rx Communications

Making molehills out of mountains — of clinical data | Rx Communications

4th Annual World Health Care Congress | Rx Communications

Industry commentary — Compulsory licences in Thailand override international patents | Rx Communications

How to write a book review | Rx Communications

Scientific conferences: time for rigorous appraisal | Rx Communications

Prevention information on the Internet | Rx Communications

Bridging cultural gaps | Rx Communications

Observational studies: answering real-life questions about healthcare practice | Rx Communications

Presenteeism and the impact of appropriate pharmaceutical treatment on workplace costs | Rx Communications

Drowning in email? Here are some life belts | Rx Communications

ASHE revisited | Rx Communications

ISPOR’s 12th annual international meeting | Rx Communications

HOC people: Alan Bakst | Rx Communications

WHC and ISMMP congresses | Rx Communications

Profile: Health policy academics Jennifer Lofland and Laura Pizzi | Rx Communications

Ethics in publishing: Conflict of interest | Rx Communications

4th Annual World Health Care Congress | Rx Communications

Top clichés of 2006 | Rx Communications

How Australia’s drug approval process works | Rx Communications

Coping with information overload | Rx Communications

The rewards of research | Rx Communications

Drug approval agencies | Rx Communications

Profile: Madhusree Singh, health economist | Rx Communications

How to make the best use of graphics: Line graphs | Rx Communications

Ethics in publishing: Authorship | Rx Communications

ISPOR 9th Annual European meeting at Copenhagen | Rx Communications

Maintaining good relationships with your chosen agency | Rx Communications

How health economists can develop a global perspective | Rx Communications

Ethics in publishing: Plagiarism | Rx Communications

Choosing a specific agency | Rx Communications

The essentials of foolproof proofreading | Rx Communications

Overcoming writer’s block | Rx Communications

The Gunning Fog Index: a useful tool for targeting an article to an audience | Rx Communications

Book review: Methods for the economic evaluation of health care programmes — 3rd edition | Rx Communications

What is an editorial? | Rx Communications

Watch your language | Rx Communications

Macro- and micro-editing | Rx Communications

How to select a healthcare agency | Rx Communications

Book review: Prevention effectiveness — 2nd edition | Rx Communications

Search HOC

Callback Form

HOC Signup Form